Michele Jordan

Michele Jordan is currently the Global Director of Study Operations, Early Oncology at AstraZeneca, a position held since 2021. They have extensive experience in clinical research, having served in various roles including Senior Clinical Project Manager at MedImmune, LLC from 2008 to 2018, and Associate Director of Clinical Operations at AstraZeneca from 2018 to 2021. Previously, Michele worked as a Clinical Studies Coordinator at SangStat Medical Corporation and held multiple positions at MedImmune from 2003 to 2018. They began their career as a Transplant Research Assistant/Coordinator at Medlantic Research Institute and are pursuing a Bachelor of Science in Chemistry with a concentration in Pre-Med at Norfolk State University.